🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with tirzepatide and fatty liver? Page 7

Has anyone dealt with tirzepatide and fatty liver?

Dr.PeteFamMed Tue, Nov 18, 2025 at 6:29 PM 39 replies 1,964 viewsPage 7 of 8
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Dec 1, 2025 at 10:50 PM#31
VendorMark said:
Keep the original post as written when you update it, and add the correction underneath.

Bookmarking. The distinction being drawn above is the one nobody else makes. Printing the relevant bit and taking it with me.

8 8COA_Karl, MikeFit_NJ, InsuranceTom and 5 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Dec 2, 2025 at 10:47 PM#32

From the other side of the consultation, briefly. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

That is the short version; the long version is somebody else's post.

7 7mark_tokyo, hans_munich, jason_sac26 and 4 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Dec 3, 2025 at 10:44 PM#33
julia.endo said:
It helps to ask what evidence would change your mind before you look at any.

This is my experience too, for whatever a second data point is worth.

6 6cory_ATX, lori_vegas, Dr.PulmRoch and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
B12Beth
Member
289
890
Oct 2024
Maryland
Dec 4, 2025 at 10:42 PM#34
julia.endo said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Ask again with the specifics and you will get a better answer than this one.

5 5marco_milano, pam_columbus, nick_SD_fit and 2 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Dec 5, 2025 at 10:40 PM#35

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

4 4TrialTracker_MD, JennaRN, LabKate and 1 other
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register